Industry Developments

BMI View: It seems that Acino has paid a very good price for Cephalon's emerging market businesses because of regional political tension. Acino's strategy to focus on the markets of... 2012-03-14

BMI View: Ranbaxy's decision to establish a pharmaceutical manufacturing facility in Morocco is strategically wise given the country's favourable business environment, strong generic... 2012-03-14

BMI View: New population figures for 2011 show the size of the expatriate population in the UAE has been underappreciated. The increase in population size has fed through to an increase... 2012-03-13

BMI View: One of the biggest factors determining the success of an exporter to a Sub-Saharan African market is existing business ties stemming from the colonial period. For example,... 2012-03-09

BMI View: While BMI is glad that historic healthcare expenditure numbers for Iraq from the World Healthcare Organisation (WHO) have increased significantly, reconciling differences... 2012-03-08

BMI View: Obesity, urbanisation and increasingly sedentary lifestyles are driving the increase in incidence of diabetes and cardiovascular disease in Africa, a region not normally associated... 2012-03-08

BMI View: With rapid growth forecast in the Middle East and Africa's healthcare markets, drugmakers should be considering new strategies for pharmaceutical packaging and marketing to... 2012-03-07

BMI View: We like Julphar's regional strategy, especially its diversified product portfolio with sales across the Middle East and North Africa. Its latest project appears to be a lower... 2012-03-06

BMI View: Multilateral non-governmental organisations (NGOs) such as The Global Fund undermine the size of the African pharmaceutical market for domestic drugmakers. Unfortunately,... 2012-03-05

BMI View: Staff shortages in Kenya have historically presented problems for the public and private healthcare systems. The government's focus on this issue seems to be having a real... 2012-03-02